CClinicalTrials.gg
Status unknownNCT04899531PANGeA_MMUpdated May 25, 2021

PANGeA - Physical Activity and Nutrition for Quality Ageing

An observational study in Aging, Sarcopenia and Cognitive Decline, sponsored by Science and Research Centre Koper. Status unknown at 1 site in Slovenia. Open to participants aged 60 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-05-25.

Sponsored by Science and Research Centre Koper · Observational

The sponsor has not verified this record recently (last verified May 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
950
Ages
60 Years to 100 Years
Sex
All
01

Study summary

General objectives of the project

Defining healthy ageing factors; Setting up content-related bases of the international excellence centre (SLO-ITA) in the field of health of elderly citizens; Raising awareness on the significance of healthy ageing, social inclusion and mobility of less privileged populations (the elderly); Reducing the costs of health care; Connecting the existing health care, social and private entities and improving their mutual coordination.

Read the detailed description

Physical activity, dietary habits, social and private entities strongly affect the quality of health and quality of life of the elderly. The main object of this study will be to evaluate physical and cognitive performance in combination with physical activity and dietary habits of the elderly. The investigators are interested in longitudinal monitoring of the elderly that participated in measurements in 2013 and measurements after a decade. The results of this study will give important epidemiological information about physical and cognitive status, health status in combination with physical activity which occurs in a longer period of time.

02

Conditions studied

  • Aging
  • Sarcopenia
  • Cognitive Decline

Keywords

  • elderly
  • longitudinal
  • physical activity
  • cognition
  • dietary habits
03

In context

Sarcopenia

1,206 studies on the registry are indexed under Sarcopenia; 401 are open to participants now.

This study's planned enrollment of 950 is above the median of 120 across 419 observational studies indexed under Sarcopenia.

Browse Sarcopenia studies →

Lead sponsor

Science and Research Centre Koper is the lead sponsor of 12 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All males and females who participated in PANGeA mass measurements in 2013 will bi considered in the study.

Inclusion criteria

  • singed written consent
  • age above 60
  • healthy

Exclusion criteria

Exclusion Criteria:

  • severe musculoskeletal injuries
  • inability to follow instructions when performing the test
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
950 participants (estimated)
Patient registry
No

Groups and cohorts

  • Longitudinal observation

    No specific intervention, pre-post measurements only

    Other: Longitudinal observation

Interventions

  • OtherLongitudinal observation

    No specific intervention, longitudinal (pre-post measurements) only

06

What researchers measure

Primary outcomes

  1. Grip strength

    Grip strength measured using a hand-held dynamometer

    Time frame: change in grip strength between two observational time points (pre-post 8-10years)

Secondary outcomes

  1. Gait speed

    Gait speed measured for four meters self selected speed

    Time frame: change in gait speed between two observational time points (pre-post 8-10years)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 25, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04899531
Lead sponsor
Science and Research Centre Koper
Responsible party
Rado Pisot (Professor, Science and Research Centre Koper) — Principal investigator
First posted
May 24, 2021
Start date
Apr 1, 2013
Primary completion
Apr 1, 2023 (estimated)
Completion
Apr 1, 2023 (estimated)
Last update
May 25, 2021

Study contacts

Kaja Teraž, MSc
Contact
kaja.teraz@zrs-kp.si
Rado Pišot, PhD
study director · Science and Research Centre Koper

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion